Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 2/20 | 0.39 |
| ▸ | IDO1 | P14902 | 1/20 | 0.37 |
| ▸ | TDO2 | P48775 | 1/20 | 0.37 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.36 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.32 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.32 |
| ▸ | SOS1 | Q07889 | 3/20 | 0.31 |
| ▸ | CCR1 | P32246 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3419587 | 0.83 | CES2 (0.33) | — | |
| Rezatomidine SCHEMBL7799658 | 0.74 | ADRA2A (0.53) | — | |
| Rezatomidine SCHEMBL676215 | 0.74 | ADRA2A (0.53) | — | |
| Rezatomidine SCHEMBL345466 | 0.74 | ADRA2A (0.53) | — | |
| SCHEMBL3749391 | 0.71 | ADRA2A (0.55) | — | |
| SCHEMBL12009462 | 0.70 | P2RX7 (0.50) | PDE2AIDO1TDO2P2RX7CCR1 | |
| SCHEMBL3419479 | 0.69 | PDE2A (0.40) | PDE2AIDO1TDO2P2RX7GRIN1 | |
| SCHEMBL14546567 | 0.69 | ADRA2A (0.38) | — | |
| SCHEMBL698140 | 0.69 | ADRA2A (0.53) | PDE2AIDO1TDO2P2RX7GRIN1 | |
| SCHEMBL25019477 | 0.68 | IDO1 (0.47) | PDE2AIDO1TDO2P2RX7GRIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7683089-B1 | 4-(Phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists | ALLERGAN, INC (US) | 2010-03-23 | — | — | US | disclosed |
| US-7683089-B1 | 4-(Phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists | ALLERGAN, INC (US) | 2010-03-23 | — | — | US | disclosed |
| US-7683089-B1 | 4-(Phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists | ALLERGAN, INC (US) | 2010-03-23 | — | — | US | disclosed |